# Larimar Therapeutics, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 21:18 ET
- Period: 2026-01-12
- Accession: 0001193125-26-010409
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312526010409/lrmr-20260112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312526010409/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312526010409/lrmr-20260112.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-010409. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.